2018-2025 Ocular Drug Delivery Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

January 2018 | 126 pages | ID: 24466F31F21EN
QYResearch

Abstracts

Summary

This report studies the Ocular Drug Delivery market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Ocular Drug Delivery market by product type and application/end industries.

The global Ocular Drug Delivery market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Ocular Drug Delivery.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Ocular Drug Delivery in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• OCULAR THERAPEUTIX, INC
• Alimera Sciences
• Allergan, Plc
• EyeGate Pharma
• Valeant Pharmaceuticals International, Inc
• Envisia Therapeutics
• Clearside Biomedical
• Graybug Vision Inc
• Taiwan Liposome Company
• Santen Pharmaceutical Co., Ltd

On the basis of product, the market is primarily split into

• By Technology
• By Form

On the basis on the end users/application, this report covers

• Hospitals
• Ambulatory Surgical Centers
• Ophthalmic Clinics
• Homecare Settings

Contents

2018-2025 OCULAR DRUG DELIVERY REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 OCULAR DRUG DELIVERY MARKET OVERVIEW

2.1 Ocular Drug Delivery Product Overview
2.2 Ocular Drug Delivery Market Segment by Type
  2.2.1 By Technology
  2.2.2 By Form
2.3 Global Ocular Drug Delivery Product Segment by Type
  2.3.1 Global Ocular Drug Delivery Sales (K Doses) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Ocular Drug Delivery Sales (K Doses) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Ocular Drug Delivery Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Ocular Drug Delivery Price (USD/Dose) by Type (2013-2018)
2.4 United States Ocular Drug Delivery Product Segment by Type
  2.4.1 United States Ocular Drug Delivery Sales (K Doses) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Ocular Drug Delivery Sales (K Doses) and Market Share by Type (2013-2018)
  2.4.3 United States Ocular Drug Delivery Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Ocular Drug Delivery Price (USD/Dose) by Type (2013-2018)

3 OCULAR DRUG DELIVERY APPLICATION/END USERS

3.1 Ocular Drug Delivery Segment by Application/End Users
  3.1.1 Hospitals
  3.1.2 Ambulatory Surgical Centers
  3.1.3 Ophthalmic Clinics
  3.1.4 Homecare Settings
3.2 Global Ocular Drug Delivery Product Segment by Application
  3.2.1 Global Ocular Drug Delivery Sales (K Doses) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Ocular Drug Delivery Sales (K Doses) and Market Share (%) by Application (2013-2018)
3.3 United States Ocular Drug Delivery Product Segment by Application
  3.3.1 United States Ocular Drug Delivery Sales (K Doses) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Ocular Drug Delivery Sales (K Doses) and Market Share (%) by Application (2013-2018)

4 OCULAR DRUG DELIVERY MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Ocular Drug Delivery Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Ocular Drug Delivery Sales and Revenue by Regions
  4.2.1 Global Ocular Drug Delivery Sales (K Doses) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Ocular Drug Delivery Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  4.2.4 North America Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  4.2.7 South America Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  4.2.9 United States Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)

5 GLOBAL OCULAR DRUG DELIVERY MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Ocular Drug Delivery Sales (K Doses) and Market Share by Players (2013-2018)
5.2 Global Ocular Drug Delivery Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Ocular Drug Delivery Average Price (USD/Dose) by Players (2013-2018)
5.4 Global Top Players Ocular Drug Delivery Manufacturing Base Distribution, Sales Area, Product Types
5.5 Ocular Drug Delivery Market Competitive Situation and Trends
  5.5.1 Ocular Drug Delivery Market Concentration Rate
  5.5.2 Global Ocular Drug Delivery Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES OCULAR DRUG DELIVERY MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Ocular Drug Delivery Sales (K Doses) and Market Share by Players (2013-2018)
6.2 United States Ocular Drug Delivery Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Ocular Drug Delivery Average Price (USD/Dose) by Players (2013-2018)
6.4 United States Ocular Drug Delivery Market Share (%) of Top 3 and Top 5 Players

7 OCULAR DRUG DELIVERY PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 OCULAR THERAPEUTIX, INC
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Ocular Drug Delivery Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Alimera Sciences
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Ocular Drug Delivery Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Allergan, Plc
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Ocular Drug Delivery Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 EyeGate Pharma
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Ocular Drug Delivery Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Valeant Pharmaceuticals International, Inc
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Ocular Drug Delivery Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 Envisia Therapeutics
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Ocular Drug Delivery Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Clearside Biomedical
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Ocular Drug Delivery Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Graybug Vision Inc
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Ocular Drug Delivery Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview
7.9 Taiwan Liposome Company
  7.9.1 Company Basic Information, Manufacturing Base and Competitors
  7.9.2 Ocular Drug Delivery Product Category, Application and Specification
    7.9.2.1 Product A
    7.9.2.2 Product B
  7.9.3 Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  7.9.4 Main Business/Business Overview
7.10 Santen Pharmaceutical Co., Ltd
  7.10.1 Company Basic Information, Manufacturing Base and Competitors
  7.10.2 Ocular Drug Delivery Product Category, Application and Specification
    7.10.2.1 Product A
    7.10.2.2 Product B
  7.10.3 Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
  7.10.4 Main Business/Business Overview

8 OCULAR DRUG DELIVERY MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Ocular Drug Delivery Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Ocular Drug Delivery Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL OCULAR DRUG DELIVERY MARKET FORECAST

10.1 Global Ocular Drug Delivery Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
  10.1.1 Global Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Ocular Drug Delivery Market Forecast
  10.2.1 United States Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Ocular Drug Delivery Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Ocular Drug Delivery Forecast by Regions
  10.3.1 North America Ocular Drug Delivery Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Ocular Drug Delivery Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Ocular Drug Delivery Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Ocular Drug Delivery Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Ocular Drug Delivery Sales (K Doses) and Revenue (Million USD) Forecast (2018-2025)
10.4 Ocular Drug Delivery Forecast by Type
  10.4.1 Global Ocular Drug Delivery Sales (K Doses) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Ocular Drug Delivery Sales (K Doses) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Ocular Drug Delivery Forecast by Application
  10.5.1 Global Ocular Drug Delivery Sales (K Doses) Forecast by Application (2018-2025)
  10.5.2 United States Ocular Drug Delivery Sales (K Doses) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Ocular Drug Delivery Product Picture
Figure Global Ocular Drug Delivery Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Ocular Drug Delivery Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of By Technology
Table Major Players of By Technology
Figure Global By Technology Sales (K Doses) and Growth Rate (%)(2013-2018)
Figure Product Picture of By Form
Table Major Players of By Form
Figure Global By Form Sales (K Doses) and Growth Rate (%)(2013-2018)
Table Global Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Ocular Drug Delivery Sales (K Doses) by Type (2013-2018)
Table Global Ocular Drug Delivery Sales Share (%) by Type (2013-2018)
Figure Global Ocular Drug Delivery Sales Market Share (%) by Type (2013-2018)
Figure Global Ocular Drug Delivery Sales Market Share (%) by Type in 2017
Table Global Ocular Drug Delivery Revenue (Million USD) by Type (2013-2018)
Table Global Ocular Drug Delivery Revenue Share (%) by Type (2013-2018)
Figure Global Ocular Drug Delivery Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Ocular Drug Delivery Revenue Market Share (%) by Type
Table Global Ocular Drug Delivery Price (USD/Dose) by Type (2013-2018)
Table United States Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Ocular Drug Delivery Sales (K Doses) by Type (2013-2018)
Table United States Ocular Drug Delivery Sales Share (%) by Type (2013-2018)
Figure United States Ocular Drug Delivery Sales Market Share (%) by Type (2013-2018)
Figure United States Ocular Drug Delivery Sales Market Share (%) by Type in 2017
Table United States Ocular Drug Delivery Revenue (Million USD) by Type (2013-2018)
Table United States Ocular Drug Delivery Revenue Share (%) by Type (2013-2018)
Figure United States Ocular Drug Delivery Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Ocular Drug Delivery Revenue Market Share (%) by Type
Table United States Ocular Drug Delivery Price (USD/Dose) by Type (2013-2018)
Figure Hospitals Examples
Figure Ambulatory Surgical Centers Examples
Figure Ophthalmic Clinics Examples
Figure Homecare Settings Examples
Table Global Ocular Drug Delivery Sales (K Doses) Comparison by Application (2013-2025)
Table Global Ocular Drug Delivery Sales (K Doses) by Application (2013-2018)
Table Global Ocular Drug Delivery Sales Share (%) by Application (2013-2018)
Figure Global Ocular Drug Delivery Sales Market Share (%) by Application (2013-2018)
Figure Global Ocular Drug Delivery Sales Market Share (%) by Application in 2017
Table United States Ocular Drug Delivery Sales (K Doses) Comparison by Application (2013-2025)
Table United States Ocular Drug Delivery Sales (K Doses) by Application (2013-2018)
Table United States Ocular Drug Delivery Sales Share (%) by Application (2013-2018)
Figure United States Ocular Drug Delivery Sales Market Share (%) by Application (2013-2018)
Figure United States Ocular Drug Delivery Sales Market Share (%) by Application in 2017
Table Global Ocular Drug Delivery Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Ocular Drug Delivery Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Ocular Drug Delivery Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Ocular Drug Delivery Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Ocular Drug Delivery Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Ocular Drug Delivery Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Ocular Drug Delivery Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Ocular Drug Delivery Sales (K Doses) by Regions (2013-2018)
Figure Global Ocular Drug Delivery Sales Market Share (%) by Regions (2013-2018)
Figure Global Ocular Drug Delivery Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Ocular Drug Delivery Sales Market Share (%) by Regions
Figure 2017 United States Ocular Drug Delivery Sales Market Share (%) in Global Market
Table Global Ocular Drug Delivery Revenue (Million USD) by Regions (2013-2018)
Table Global Ocular Drug Delivery Revenue Market Share (%) by Regions (2013-2018)
Figure Global Ocular Drug Delivery Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Ocular Drug Delivery Revenue Market Share (%) by Regions
Figure 2017 United States Ocular Drug Delivery Revenue Market Share (%) in Global Market
Table Global Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table North America Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Europe Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table South America Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table United States Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Table Global Ocular Drug Delivery Sales (K Doses) of Key Players (2013-2018)
Table Global Ocular Drug Delivery Sales Share (%) by Players (2013-2018)
Figure 2017 Global Ocular Drug Delivery Sales Share (%) by Players
Figure 2018 Global Ocular Drug Delivery Sales Share (%) by Players
Table Global Ocular Drug Delivery Revenue (Million USD) by Players (2013-2018)
Table Global Ocular Drug Delivery Revenue Share (%) by Players (2013-2018)
Table 2017 Global Ocular Drug Delivery Revenue Share (%) by Players
Table 2017 Global Ocular Drug Delivery Revenue Share (%) by Players
Table Global Market Ocular Drug Delivery Average Price (USD/Dose) by Players (2013-2018)
Table Global Ocular Drug Delivery Top Players Manufacturing Base Distribution and Sales Area
Table Global Ocular Drug Delivery Top Players Product Category
Figure Global Ocular Drug Delivery Market Share (%) of Top 3 Players
Figure Global Ocular Drug Delivery Market Share (%) of Top 5 Players
Table United States Ocular Drug Delivery Sales (K Doses) by Players (2013-2018)
Table United States Ocular Drug Delivery Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Ocular Drug Delivery Sales Share (%) by Players
Figure 2018 United States Ocular Drug Delivery Sales Share (%) by Players
Table United States Ocular Drug Delivery Revenue (Million USD) by Players (2013-2018)
Table United States Ocular Drug Delivery Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Ocular Drug Delivery Revenue Share (%) by Players
Table 2017 United States Ocular Drug Delivery Revenue Share (%) by Players
Table United States Market Ocular Drug Delivery Average Price (USD/Dose) by Players (2013-2018)
Figure United States Ocular Drug Delivery Market Share (%) of Top 3 Players
Figure United States Ocular Drug Delivery Market Share (%) of Top 5 Players
Table OCULAR THERAPEUTIX, INC Basic Information List
Table OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales Growth Rate (2013-2018)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Sales Global Market Share (%)(2013-2018)
Figure OCULAR THERAPEUTIX, INC Ocular Drug Delivery Revenue Global Market Share (%)(2013-2018)
Table Alimera Sciences Basic Information List
Table Alimera Sciences Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Alimera Sciences Ocular Drug Delivery Sales Growth Rate (2013-2018)
Figure Alimera Sciences Ocular Drug Delivery Sales Global Market Share (%)(2013-2018)
Figure Alimera Sciences Ocular Drug Delivery Revenue Global Market Share (%)(2013-2018)
Table Allergan, Plc Basic Information List
Table Allergan, Plc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Allergan, Plc Ocular Drug Delivery Sales Growth Rate (2013-2018)
Figure Allergan, Plc Ocular Drug Delivery Sales Global Market Share (%)(2013-2018)
Figure Allergan, Plc Ocular Drug Delivery Revenue Global Market Share (%)(2013-2018)
Table EyeGate Pharma Basic Information List
Table EyeGate Pharma Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure EyeGate Pharma Ocular Drug Delivery Sales Growth Rate (2013-2018)
Figure EyeGate Pharma Ocular Drug Delivery Sales Global Market Share (%)(2013-2018)
Figure EyeGate Pharma Ocular Drug Delivery Revenue Global Market Share (%)(2013-2018)
Table Valeant Pharmaceuticals International, Inc Basic Information List
Table Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales Growth Rate (2013-2018)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Sales Global Market Share (%)(2013-2018)
Figure Valeant Pharmaceuticals International, Inc Ocular Drug Delivery Revenue Global Market Share (%)(2013-2018)
Table Envisia Therapeutics Basic Information List
Table Envisia Therapeutics Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Envisia Therapeutics Ocular Drug Delivery Sales Growth Rate (2013-2018)
Figure Envisia Therapeutics Ocular Drug Delivery Sales Global Market Share (%)(2013-2018)
Figure Envisia Therapeutics Ocular Drug Delivery Revenue Global Market Share (%)(2013-2018)
Table Clearside Biomedical Basic Information List
Table Clearside Biomedical Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Clearside Biomedical Ocular Drug Delivery Sales Growth Rate (2013-2018)
Figure Clearside Biomedical Ocular Drug Delivery Sales Global Market Share (%)(2013-2018)
Figure Clearside Biomedical Ocular Drug Delivery Revenue Global Market Share (%)(2013-2018)
Table Graybug Vision Inc Basic Information List
Table Graybug Vision Inc Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Graybug Vision Inc Ocular Drug Delivery Sales Growth Rate (2013-2018)
Figure Graybug Vision Inc Ocular Drug Delivery Sales Global Market Share (%)(2013-2018)
Figure Graybug Vision Inc Ocular Drug Delivery Revenue Global Market Share (%)(2013-2018)
Table Taiwan Liposome Company Basic Information List
Table Taiwan Liposome Company Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Taiwan Liposome Company Ocular Drug Delivery Sales Growth Rate (2013-2018)
Figure Taiwan Liposome Company Ocular Drug Delivery Sales Global Market Share (%)(2013-2018)
Figure Taiwan Liposome Company Ocular Drug Delivery Revenue Global Market Share (%)(2013-2018)
Table Santen Pharmaceutical Co., Ltd Basic Information List
Table Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (%)(2013-2018)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales Growth Rate (2013-2018)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Sales Global Market Share (%)(2013-2018)
Figure Santen Pharmaceutical Co., Ltd Ocular Drug Delivery Revenue Global Market Share (%)(2013-2018)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Ocular Drug Delivery
Figure Ocular Drug Delivery Industrial Chain Analysis
Table Major Buyers of Ocular Drug Delivery
Table Distributors/Traders List
Figure Global Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Global Ocular Drug Delivery Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Ocular Drug DeliveryOcular Drug Delivery Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure United States Ocular Drug Delivery Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Ocular Drug Delivery Sales (K Doses) Forecast by Regions (2018-2025)
Figure Global Ocular Drug Delivery Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure North America Ocular Drug Delivery Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Ocular Drug Delivery Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Ocular Drug Delivery Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure South America Ocular Drug Delivery Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Ocular Drug Delivery Sales (K Doses) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Ocular Drug Delivery Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Ocular Drug Delivery Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Ocular Drug Delivery Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Ocular Drug Delivery Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Ocular Drug Delivery Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Ocular Drug Delivery Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Ocular Drug Delivery Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Ocular Drug Delivery Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Ocular Drug Delivery Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Ocular Drug Delivery Sales (K Doses) Forecast by Application (2018-2025)
Figure Global Ocular Drug Delivery Sales Forecast by Application (2018-2025)
Table United States Ocular Drug Delivery Sales (K Doses) Forecast by Application (2018-2025)
Figure United States Ocular Drug Delivery Sales Forecast by Application (2018-2025)